58 related articles for article (PubMed ID: 17508300)
1. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease.
Kantarci K; Xu Y; Shiung MM; O'Brien PC; Cha RH; Smith GE; Ivnik RJ; Boeve BF; Edland SD; Kokmen E; Tangalos EG; Petersen RC; Jack CR
Dement Geriatr Cogn Disord; 2002; 14(4):198-207. PubMed ID: 12411762
[TBL] [Abstract][Full Text] [Related]
2. Correlation between abnormal cellular immune and changes of magnetic resonance spectroscopy in patients with Alzheimer's disease.
Zeng H; Zhang Q; Liu L; Deng F; Han H; Meng F; Bai H
Neurochem Int; 2024 Jun; 176():105737. PubMed ID: 38599243
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer-like brain metabolic and structural features in cholesterol-fed rabbit detected by magnetic resonance imaging.
Jin P; Pan Y; Pan Z; Xu J; Lin M; Sun Z; Chen M; Xu M
Lipids Health Dis; 2018 Mar; 17(1):61. PubMed ID: 29587752
[TBL] [Abstract][Full Text] [Related]
4. Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review.
Abbaspour F; Mohammadi N; Amiri H; Cheraghi S; Ahadi R; Hormozi-Moghaddam Z
Heliyon; 2024 May; 10(9):e30521. PubMed ID: 38726104
[TBL] [Abstract][Full Text] [Related]
5. Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease.
Zhang N; Song X; Bartha R; Beyea S; D'Arcy R; Zhang Y; Rockwood K
Curr Alzheimer Res; 2014 May; 11(4):367-88. PubMed ID: 24597505
[TBL] [Abstract][Full Text] [Related]
6. Review of MR spectroscopy analysis and artificial intelligence applications for the detection of cerebral inflammation and neurotoxicity in Alzheimer's disease.
Seriramulu VP; Suppiah S; Lee HH; Jang JH; Omar NF; Mohan SN; Ibrahim NSN; Azmi NHM; Buhari I; Ahmad U
Med J Malaysia; 2024 Jan; 79(1):102-110. PubMed ID: 38287765
[TBL] [Abstract][Full Text] [Related]
7. Correction to: Magnetic Resonance Spectroscopy (MRS) in Alzheimer's Disease.
Sheikh-Bahaei N; Chen M; Pappas I
Methods Mol Biol; 2024; 2785():C1. PubMed ID: 38710984
[No Abstract] [Full Text] [Related]
8. Hydrogen Proton Magnetic Resonance Spectroscopy in Multidomain Amnestic Mild Cognitive Impairment and Vascular Cognitive Impairment Without Dementia.
Chen SQ; Cai Q; Shen YY; Xu CX; Zhou H; Zhao Z
Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):422-9. PubMed ID: 26980718
[TBL] [Abstract][Full Text] [Related]
9. A review of 1H MR spectroscopy findings in Alzheimer's disease.
Soher BJ; Doraiswamy PM; Charles HC
Neuroimaging Clin N Am; 2005 Nov; 15(4):847-52, xi. PubMed ID: 16443495
[TBL] [Abstract][Full Text] [Related]
10. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
Jones RS; Waldman AD
Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
[TBL] [Abstract][Full Text] [Related]
11. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
[TBL] [Abstract][Full Text] [Related]
12. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
[TBL] [Abstract][Full Text] [Related]
13. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
[TBL] [Abstract][Full Text] [Related]
14. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
